NCT07510334 2026-06-05VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell CarcinomaMayo ClinicPhase 2 Recruiting18 enrolled